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It is estimated that by 2010, cardiovascular disease (CVD) will be the leading cause of 
death in developing countries. In Malaysia, heart disease and disease of pulmonary 
circulation is the second major killer, making up 14.31% of total mortality reported in 
Ministry of Health (MOH), hospitals. Population studies have shown that plant 
polyphenol is inversely correlated with mortality from cardiovascular disease and 
numerous dietary flavonoids have been shown to beneficially impact toward 
atherosclerosis, including lipoprotein oxidation, blood platelet aggregation and vascular 
reactivity. There were many studied had reported that cocoa flavonoids had shown the 
similar degree towards being protective against CVD due to: antioxidant, anti-platelet, 
anti-inflammatory effects, as well as increasing HDL-c, lowering blood pressure and 
improving endothelial. However, the study on the effect of cocoa polyphenols on 
atherosclerotic plaque formation is to be documented. The present study was aimed to 
investigate the protective effects of polyphenol extract (CE) prepared from Malaysian 
cocoa powder against hypercholesterolemia atherosclerosis. Male New Zealand White 
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rabbits were fed with the experimental diets for 12 weeks. Plasma total cholesterol (TC) 
increased up to week 12 for a group fed with diet enriched with 1% of cholesterol. 
Plasma TC were significantly decreased (p < 0.01) from 5 to 12 week when CE was 
administered at a dosage of 300, 600 and 800 mg/kg body weight/day. Significant 
increament (p < 0.01) and significant decreament (p < 0.01) in plasma high density 
lipoprotein cholesterol (HDL-c) was observed from 0 to 5 week and  from 5 to 12 week, 
respectively for groups administered with CE. Plasma low density lipoprotein cholesterol 
(LDL-c) was significantly increased (p < 0.001) from initial to 5 week, and then 
decreased (p < 0.01) from 5 to 12 week in the group administered with CE, except for the 
300 mg CE group. Compared to the standard laboratory diet, cholesterol–enriched diet 
increased aortic atherosclerosis formation, hepatic superoxide dismutase (SOD), hepatic 
glutathione peroxidase (GSHPx), hepatic malondialdehyde (MDA), and kidney GSHPx. 
Administered with 800 mg of CE to rabbits fed with cholesterol-enriched diet showed 
significant increased (p < 0.05) and significant decreased (p < 0.05) for activities of 
hepatic GSHPx and MDA concentration, respectively. Significant decreased (p < 0.05) in 
MDA concentration and significant increased (p < 0.05) for activities of hepatic catalase 
(CAT) was observed in groups of 600 mg CE and 300 mg CE, respectively. 
Approximately, 50 % area of atherosclerotic lesion in the rabbits fed with cholesterol-
enrich diet could be reduced by administering with CE. The effectiveness of CE against 
hypercholesterolemic atherosclerosis could be due by its effects to lower plasma TC, 
LDL-c, increase plasma HDL-c and enhances antioxidative defenses against the oxidative 
stress imposed by hypercholesterolemia.        
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Pada tahun 2010, adalah dijangkakan bahawa penyakit kardiovaskular (PKV) akan 
menjadi penyebab utama kematian di negara-negara membangun.  Di Malaysia, penyakit 
jantung dan penyakit peredaran pulmonari adalah pembunuh kedua yang terbanyak, 
dengan jumlah mortaliti mencapai 14.31 % seperti yang dilaporkan oleh hospital-hospital 
Kementerian Kesihatan Malaysia. Kajian-kajian populasi telah menunjukkan polifenol 
tumbuhan berkadar songsang dengan kadar kematian dari penyakit kardiovaskular dan 
banyak komponen flavonoids dalam diet telah menunjukkan impak yang baik terhadap 
aterosklerosis, termasuk pengoksidaan lipoprotein, pengumpulan platelet darah dan 
reaktiviti vaskular. Sehingga kini, banyak kajian telah dilaporkan mengenai kepentingan 
(faedah) komponen flavonoid koko yang bertindak sebagai pelindung daripada PKV 
disebabkan oleh: antioksida, anti-platelet, kesan anti-inflamatori, termasuk juga 
meningkatkan HDL-c, merendahkan tekanan darah dan memperbaiki saluran endotelial 
darah. Walaubagaimanapun, kajian mengenai kesan polifenol koko ke atas pembentukan 
plak aterosklerotik masih belum dibuktikan. Kajian ini bertujuan untuk mengkaji kesan 
pencegahan ekstrak polifenol (CE) dari serbuk koko Malaysia ke atas aterosklerosis 
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hiperkolesterolemia.  Arnab jantan putih New Zealand diberi makan dengan diet-diet 
kajian selama 12 minggu.  Jumlah plasma kolesterol (TC) telah meningkat sehingga 
minggu ke-12 bagi kumpulan yang diberi diet yang diperkaya dengan 1% kolesterol.  
Plasma TC telah menurun secara signifikan (p < 0.01) dari minggu ke-5 hingga minggu 
ke-12 apabila CE diberi pada dos-dos berbeza iaitu 300, 600 dan 800 mg/ kg berat badan/ 
hari.  Kenaikkan dan penurunan yang signifikan (p < 0.01) bagi plasma lipoprotein-
kolesterol berketumpatan tinggi (HDL-c) telah diperhatikan dari awal minggu kajian 
hingga minggu ke-5 dan dari minggu ke-5 hingga minggu ke-12, masing-masing bagi 
kumpulan-kumpulan yang diberi CE. Plasma lipoprotein-kolesterol berketumpatan 
rendah (LDL-c) telah meningkat secara signifikan (p < 0.001) di awal minggu kajian 
hingga minggu ke-5 dan kemudian menurun (p<0.01) dari minggu ke-5 hingga minggu 
ke-12, bagi kumpulan yang diberi CE, kecuali kumpulan yang diberi 300 mg CE.  
Berbanding dengan diet normal, diet diperkaya kolesterol meningkatkan pembentukan 
aortik aterosklerosis, superoksida dismutase hepatik (SOD), gluthathione peroxidase 
hepatik (GSHPx), malondialdehid hepatik (MDA) dan GSHPx dalam ginjal.  Pemberian 
800 mg CE kepada arnab yang diberi makan diet diperkaya kolesterol, menunjukkan 
kenaikan signifikan (p < 0.05) dan penurunan signifikan (p < 0.05) bagi aktiviti –aktiviti 
GSHPx hepatik dan kepekatan MDA hepatik, masing-masing.  Penurunan signifikan (p < 
0.05) dalam kepekatan MDA hepatik dan kenaikan signifikan (p < 0.05) bagi aktiviti-
aktiviti katalase (CAT) hepatik telah diperhatikan dalam kumpulan 600 mg CE dan 300 
mg CE, masing-masing. Kira-kira 50 % kawasan lesi aterosklerotik pada arnab yang 
diberi diet diperkaya kolesterol dapat dikurangkan dengan memberi CE.  Keberkesanan 
CE dalam melawan hiperkolesterolemia arterosklerotik boleh ditunjukkan melalui 
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kesannya dalam menurunkan plasma TC, LDL-c, dan meningkatkan plasma HDL-c, dan 
juga meningkatkan pertahanan antioksidatif dalam melawan tekanan oksidatif yang 
dibebani oleh keadaan hiperkolesterolemia. 
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CHAPTER I 
INTRODUCTION 
 
 
Introduction 
 
Coronary heart disease (CHD) has become very common in most industrialized societies 
and it is occurring increasingly early in life. CHD is also called coronary artery disease 
and ischemic heart disease. Prevention of CHD could be done by the action predicted 
from its risk factors. 
 
CHD means a partial or complete blockage of one or more of the coronary arteries which 
supply blood to the muscular walls of the heart (the myocardium). It arises initially 
because of the development of fatty deposits in the arterial wall (atherosclerosis), which 
may affect arteries in the body, and can impair the blood supply. Fatality can occur when 
the blood supply to the heart is blocked. At the initial stage, the restriction of blood 
supply to the heart may appear as chest pain (angina), when the demand on the heart 
increases. Later, a complete blockage may occur as a result of a blood clot at the site of 
the atherosclerotic lesions (Frayn, 1996). This condition is popularly known as heart 
attack. Consequences of this event will lead to death of myocardial tissue (heart tissue) 
and interruption of the heart function (Randall and Romaine, 2005).    
There are two main events in the pathogenesis of atherosclerosis. Firstly, the lipid 
infiltration events and secondly continue on damage of the arterial wall. The lipid event 
will have fatty substances from the blood circulation, filtrate into the arterial wall. This 
event explains the high degree of atherosclerosis with fatty infiltrations in the arterial 
wall in the presence of hypercholesterolemia. According to Ross (1999), high plasma 
cholesterol concentrations, in particular those of low density lipoprotein-cholesterol 
(LDL-c) are one of the foremost risk factors for atherosclerosis. Research on the 
etiological factors bearing on heart disease, show that a key reaction is the oxidation of 
LDL-c (Zock and Katan, 1998; Fuller and Jialal, 1994; Steinberg et al. 1996, Cox and 
Cohen, 1996; Ishikawa et al. 1997). The process of atherogenesis has been considered 
due to the accumulation of lipids within the artery wall. The high level of this lipoprotein, 
its transportation to the arterial walls, and its subsequent oxidative modification, expose 
the activation and dysfunction of endothelial cell. Along with these changes, production 
of chemotactic factors attracts circulating monocytes and T-lymphocytes to the activated 
endothelium with a subsequent transmigration into the arterial intimae. Clotting of 
platelets at the site of injury is supposed to play an important role and indeed patients 
with CHD, are found to have platelets that aggregate more easily than those in normal 
individuals. Each little place of damage can thus causes platelet adhesion and later 
bleeding in the wall (Libby et al. 2002). 
 
Impact of high plasma cholesterol on CHD risk was acquired more slowly than other risk 
factors i.e., cigarette smoking and elevated blood pressure. There is evidence that a link 
between the elevations of plasma cholesterol concentrations and the development of 
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CHD (Bbrliner and Hetnecke, 1996). The driving force for this evidence was the 
cholesterol hypotheses that postulate a rising plasma cholesterol concentration enhances 
the risk of CHD whereas a falling level reduces the risk (Stoclet et al. 2004). 
 
The hypothesis that elevated plasma cholesterol causes atherosclerosis came from studies 
in laboratory animals. For example, the feeding of excess cholesterol to rabbits produced 
marked hypercholesterolemia and caused deposition of cholesterol in arteries 
(Mohamedain and Fred, 2000; Prasad, 1997). These depositions closely resemble human 
atherosclerosis. It provides a strong base of support for the concept that elevated serum 
cholesterol, particularly when the cholesterol is carried in low-density lipoproteins (LDL-
c) and remnant lipoproteins-is highly atherogenic. 
 
In addition, the cholesterol hypothesis comes from epidemiological investigations, where 
prospective and cross-sectional studies have examined the correlation between serum 
cholesterol concentrations and incidence and prevalence of CHD. A notable example 
includes the Seven Countries Study and the Framingham Heart Study (Dawber and 
Kannel, 1966) 
 
Furthermore, another cholesterol hypothesis comes from genetic disorders of lipoprotein 
metabolism. These disorders are due to genetic forms of elevated serum cholesterol 
(namely, familial hypercholesterolemia) and familial defective apolipoprotein B-100. 
Apolipoprotein B-100 serves as a ligand site for the uptake of LDL-cholesterol by 
apolipoprotein B/E receptor (LDL receptor) (Frayn, 1996). When these disorders are 
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present, coronary atherosclerosis develops rapidly, leading to early onset of CHD. 
Genetic forms of hypercholesterolemia can produce premature CHD even in the absence 
of other risk factors. The occurrence of premature CHD in persons with genetic 
hypercholesterolemia provides the strongest evidence that a high level of serum 
cholesterol is a direct cause of atherosclerosis in humans. Atherosclerosis event not only 
develop as a result of high plasma cholesterol concentration, but also from the 
disturbances of glucose metabolism.  
 
Phenolic substances, especially polyphenol containing several hydroxyl groups directly 
associated with a cyclic benzene ring, are widely distributed in plants. Polyphenol can be 
defined as part of a broader group of compounds that have antioxidant activity (Hertog et 
al. 1993; Frankel et al. 1993). Growing epidemiological evidences suggest the existence 
of a negative correlation between consumption of polyphenol-rich foods or beverages 
such as fruits, vegetables, red wine, grape juice and tea and the incidence of CHD 
(Nakachi et al. 2000; Renaud and de Lorgeril, 1992; Saint-Leger et al. 1979; Sasazuki et 
al. 2000; Knekt et al. 1996; Hertog et al. 1993; Hollman et al. 1996). By virtue of their 
chemical nature, polyphenols can acts as antioxidants and may help to maintain the 
body’s natural defences against a variety of diseases associated with oxidative stress, 
such as cancers, cardiovascular disease and inflammation. These polyphenol acts as 
hydrogen donating antioxidants and also as a chelators of metal ions, preventing metal 
catalysed formation of initiating radical species (Salah et al. 1995). Catechins (example 
of polyphenol compound) serve as powerful antioxidants for eliminating superoxide 
anion radicals (Bearden et al. 2000).  
 4
Research indicates that antioxidant may help the body cells resist damage by free 
radicals, which are formed by numerous processes (Jacob and Burri, 1996). A protective 
role of cocoa polyphenols against atherosclerosis has been suggested by several studies 
(Osakabe et al. 2001; Kondo et al. 1996). The effect is due to the antioxidant activity of 
polyphenols that can inhibit low density lipoprotein (LDL-c) from oxidation and inhibit 
platelet aggregations (Rein et al. 2000) that is central to the formation of atherosclerotic 
plaque. It is clear that the prevention or decrease of the key oxidation reactions could be 
an important means of lowering the risk of coronary heart disease. In the field of a lower 
risk of coronary heart disease, it has been shown, through studies in humans as well as 
animal models, that the intake or use of foods containing antioxidants is beneficial. 
 
Polyphenol compounds in cocoa are quite similar compared to green tea, black tea and 
wine. Tea, wine and cocoa are rich with flavanols, proanthocyanidin and anthocyanidin. 
Sanbongi et al. (1997) and Kondo et al. (1996) reported cocoa polyphenols contain 
potential antioxidant properties mainly from (-)-epicatechin, (+)-catechin, clovamide and 
quarcetin in vitro and in vivo. Osakabe et al. (1998) showed cocoa polyphenols had 
reduced significantly lipid oxidation.  
 
Cocoa is also known as Theobroma cacao, means ‘food of the God’ and it was first 
discovered in the ancient civilization of the Olmecs, Mayas and Aztecs in South America 
and Mexico. The Aztecs considered the beverage as a royal drink. Cocoa beans were 
thought to have magical powers by the Mayas and carefully used in rituals, religious 
ceremonies and healing. From sixteenth to early twentieth century, a manuscript 
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produced in Europe and Spain revealed more than 100 medicinal uses for cocoa or cocoa 
products. Three consistent roles can be attributed to this manuscript such as to treat 
emaciated patients to gain weight, to stimulate nervous system of apathetic, exhausted of 
feeble patients and to improve digestion and elimination (Dillinger et al. 2000). 
 
A growing number of evidence suggest that numerous pathobiological conditions are 
associated with an increased production of reactive oxygen species (ROS) and other 
radicals, the most prominent of which are superoxide and hydroxyl radicals and oxidants 
like H2O2 and peroxynitrite (Harrison and Ohara, 1995; Kojda and Harrison, 1999; 
Griending et al. 2000; Ferdinandy and Schulz, 2001). Several factors have been identified 
to promote significant effect towards cardiovascular health, including low density 
lipoprotein oxidation and platelet aggregation and blood vessel function (Ross and 
Epstein, 1993). Studies done in vitro and in vivo reveal that polyphenols may play a 
positive role in regulating these factors. Polyphenolic substances derived from tea and 
grape seed showed effectiveness in prevention of atherosclerosis in hypercholesterolemic 
rabbits. These studies suggested that the anti-atherosclerotic effect of this compound is 
due to inhibition of low density lipoprotein oxidation (Tjiburg et al. 1997; Yamakoshi et 
al. 1999)    
 
Lipid oxidation mainly low density lipoprotein (LDL-c) particles have an important role 
in the development of atherosclerosis (Kondo et al. 1996). The development of 
atherosclerosis is also dependent on the nitrite oxide syntheses from endothelium-
dependent relaxation system. Nitric oxide (NO), an endogenous vasodilator, has many 
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